Evolocumab: no hint of added clinical benefit according the IQWiG in Germany

IQWiG

15 December 2015 - The dossier contained no suitable data for hypercholesterolaemia or for mixed dyslipidaemia.

For more details, go to: https://www.iqwig.de/en/press/press-releases/press-releases/evolocumab-no-hint-of-added-benefit.7101.html

Michael Wonder

Posted by:

Michael Wonder